The Anesthesiologists’ Perception of Malignant Hyperthermia and Availability of Dantrolene in China: A Cross-Sectional Survey
Risk Management and Healthcare Policy · 2024-03 · Volume 17 · 763-773
DOI: 10.2147/rmhp.s454895 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Risk Management and Healthcare Policy, 2024-03. Verfasst von Jiechu Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Peking University Third Hospital, Beijing, 100191, People's Republic of China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Malignant hyperthermia (MH) is a hypermetabolic syndrome with high mortality rates. Early detection and prompt intravenous administration of dantrolene are crucial for effective management of MH. However, there is currently a lack of comprehensive nationwide surveys on the availability of dantrolene and anesthesiologists' understanding of MH in China.
Methods
A nationwide survey was conducted between January 2022 and June 2022. Online questionnaires on the cognition of MH among anesthesiologists in China were sent through social platforms to anesthesiologists in mainland China. Data regarding participants' perception of MH-related knowledge, availability of domestic dantrolene, and reported MH cases were collected in this study.
Results
Responses were collected from a total of 11,354 anesthesiologists representing 31 provinces across the Chinese mainland. Among the 11 scoring questions, the highest accuracy rates were observed for the question regarding therapeutic drugs for MH (99.3%) and the characteristics of MH (98.0%). Conversely, the question pertaining to the earliest clinical signs of MH had the lowest accuracy rate (23.5%). Significant variations were observed in the scores among different professional titles (P=0.003), academic degree (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
- Beijing Center of Quality Control and Improvement on Clinical Anesthesia, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
- Anesthesia and Perioperative Medicine Branch of China International Exchange and Promotive Association for Medical and Health Care (CPAM), Beijing, 100191, People's Republic of China.
- Research Center for Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Zitieren
APA
Wang, J., Yu, Y., Gao, Y., Wan, T., Cong, Z., Li, Z., Zhou, Y., Wang, X., Feng, L., Han, Y., Zhang, J., Qu, Y., & Guo, X. (2024). The Anesthesiologists’ Perception of Malignant Hyperthermia and Availability of Dantrolene in China: A Cross-Sectional Survey. Risk Management and Healthcare Policy, Volume 17, 763-773. https://doi.org/10.2147/rmhp.s454895
Vancouver
Wang J, Yu Y, Gao Y, Wan T, Cong Z, Li Z, et al. The Anesthesiologists’ Perception of Malignant Hyperthermia and Availability of Dantrolene in China: A Cross-Sectional Survey. Risk Management and Healthcare Policy. 2024;Volume 17:763-773. doi:10.2147/rmhp.s454895
BibTeX
@article{Wang2024,
author = {Wang, Jiechu and Yu, Yao and Gao, Ya and Wan, Tingting and Cong, Zhukai and Li, Zhengqian and Zhou, Yang and Wang, Xiaoxiao and Feng, Luyang and Han, Yongzheng and Zhang, Jing and Qu, Yinyin and Guo, Xiangyang},
title = {The Anesthesiologists’ Perception of Malignant Hyperthermia and Availability of Dantrolene in China: A Cross-Sectional Survey},
journal = {Risk Management and Healthcare Policy},
year = {2024},
volume = {Volume 17},
pages = {763--773},
doi = {10.2147/rmhp.s454895}
}
EUVIMED